Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
673 Results for "
K-Ras
" in MedChemExpress (MCE) Product Catalog:
Products (673)
673 Results for "K-Ras" in MCE Product Catalog:
Cat. No.: HY-P7805
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: KRas; KRas-Enoph1 Fusion Protein; Prev. KRas2; PR310 C-K-Ras Oncogene; GTPase KRas; Small Monomeric GTPase; K-Ras4B; C-Kirsten-Ras Protein; KRas1; Proto-Oncogene GTPase; V-Ki-Ras2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog; KRas-ENOPH Fusion; Kirsten Ra
Species:
Human
Source:
E. coli
Cat. No.: HY-P70153
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: KRas; KRas-Enoph1 Fusion Protein; Prev. KRas2; PR310 C-K-Ras Oncogene; GTPase KRas; Small Monomeric GTPase; K-Ras4B; C-Kirsten-Ras Protein; KRas1; Proto-Oncogene GTPase; V-Ki-Ras2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog; KRas-ENOPH Fusion; Kirsten Ra
Species:
Human
Source:
E. coli
Cat. No.: HY-P70232
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: KRas; KRas-Enoph1 Fusion Protein; Prev. KRas2; PR310 C-K-Ras Oncogene; GTPase KRas; Small Monomeric GTPase; K-Ras4B; C-Kirsten-Ras Protein; KRas1; Proto-Oncogene GTPase; V-Ki-Ras2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog; KRas-ENOPH Fusion; Kirsten Ra
Species:
Human
Source:
E. coli
Cat. No.: HY-P70234
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: KRas; KRas-Enoph1 Fusion Protein; Prev. KRas2; PR310 C-K-Ras Oncogene; GTPase KRas; Small Monomeric GTPase; K-Ras4B; C-Kirsten-Ras Protein; KRas1; Proto-Oncogene GTPase; V-Ki-Ras2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog; KRas-ENOPH Fusion; Kirsten Ra
Species:
Human
Source:
E. coli
Cat. No.: HY-P704177
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: KRas; KRas-Enoph1 Fusion Protein; Prev. KRas2; PR310 C-K-Ras Oncogene; GTPase KRas; Small Monomeric GTPase; K-Ras4B; C-Kirsten-Ras Protein; KRas1; Proto-Oncogene GTPase; V-Ki-Ras2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog; KRas-ENOPH Fusion; Kirsten Ra
Species:
Human
Source:
E. coli
Cat. No.: HY-P704747
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: KRas; KRas-Enoph1 Fusion Protein; Prev. KRas2; PR310 C-K-Ras Oncogene; GTPase KRas; Small Monomeric GTPase; K-Ras4B; C-Kirsten-Ras Protein; KRas1; Proto-Oncogene GTPase; V-Ki-Ras2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog; KRas-ENOPH Fusion; Kirsten Ra
Species:
Human
Source:
E. coli
Cat. No.: HY-P704750
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: KRas; KRas-Enoph1 Fusion Protein; Prev. KRas2; PR310 C-K-Ras Oncogene; GTPase KRas; Small Monomeric GTPase; K-Ras4B; C-Kirsten-Ras Protein; KRas1; Proto-Oncogene GTPase; V-Ki-Ras2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog; KRas-ENOPH Fusion; Kirsten Ra
Species:
Human
Source:
E. coli
Cat. No.: HY-P704748
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: KRas; KRas-Enoph1 Fusion Protein; Prev. KRas2; PR310 C-K-Ras Oncogene; GTPase KRas; Small Monomeric GTPase; K-Ras4B; C-Kirsten-Ras Protein; KRas1; Proto-Oncogene GTPase; V-Ki-Ras2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog; KRas-ENOPH Fusion; Kirsten Ra
Species:
Human
Source:
E. coli
Cat. No.: HY-P704749
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: KRas; KRas-Enoph1 Fusion Protein; Prev. KRas2; PR310 C-K-Ras Oncogene; GTPase KRas; Small Monomeric GTPase; K-Ras4B; C-Kirsten-Ras Protein; KRas1; Proto-Oncogene GTPase; V-Ki-Ras2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog; KRas-ENOPH Fusion; Kirsten Ra
Species:
Human
Source:
E. coli
Cat. No.: HY-P704751
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: KRas; KRas-Enoph1 Fusion Protein; Prev. KRas2; PR310 C-K-Ras Oncogene; GTPase KRas; Small Monomeric GTPase; K-Ras4B; C-Kirsten-Ras Protein; KRas1; Proto-Oncogene GTPase; V-Ki-Ras2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog; KRas-ENOPH Fusion; Kirsten Ra
Species:
Human
Source:
E. coli
Cat. No.: HY-151014
CAS No.: 1698025-19-2
Research Areas:
KRAS ligand 1 is a KRAS G12C ligand and can be used for the synthesis of PROTACs, such as PROTAC KRAS G12C degrader-1 (HY-139186) .
Cat. No.: HY-146544
CAS No.: 2230873-78-4
KRAS inhibitor-14 (compound 3-22) is a potent KRAS G12C inhibitor with an IC50 of 0.249 µM. KRAS inhibitor-14 shows p-ERK inhibition activities with IC50s of 1.12, >33.3 µM in MIA PaCA-2, A549 cells, respectively. KRAS inhibitor-14 has the potential for the research of pancreatic, colorectal, and lung cancers .
Cat. No.: HY-146545
CAS No.: 2230873-75-1
KRAS inhibitor-15 (compound 3-19) is a potent KRAS G12C inhibitor with an IC50 of 0.954 µM. KRAS inhibitor-15 shows p-ERK inhibition activities with IC50s of 2.03, >33.3 µM in MIA PaCA-2, A549 cells, respectively. KRAS inhibitor-15 has the potential for the research of pancreatic, colorectal, and lung cancers .
Cat. No.: HY-146546
CAS No.: 2230873-67-1
KRAS inhibitor-16 (compound 3-11) is a potent KRAS G12C inhibitor with an IC50 of 0.457 µM. KRAS inhibitor-16 shows p-ERK inhibition activities with IC50s of 3.06, 11.1 µM in MIA PaCA-2, A549 cells, respectively. KRAS inhibitor-16 has the potential for the research of pancreatic, colorectal, and lung cancers .
Cat. No.: HY-P11357
CAS No.: 1932689-40-1
Cat. No.: HY-176523
CAS No.: 3018057-89-8
KRAS G12D inhibitor 29 (Compound Formula (I)) is an orally active and selective KRAS G12D mutant inhibitor. KRAS G12D inhibitor 29 blocks downstream signaling pathways mediated by KRAS G12D, suppressing tumor cell proliferation. KRAS G12D inhibitor 29 is promising for research of KRAS G12D mutation-related cancers (such as pancreatic cancer, lung cancer, colorectal cancer) .
Cat. No.: HY-P11357A
Cat. No.: HY-179414
CAS No.: 3102130-17-3
KRAS G12D-IN-34 (Compound 13) is a KRAS (G12D) inhibitor with IC50 values for KRAS (G12D) and KRAS (WT) of 1.05 nM and 1.59 μM respectively. KRAS G12D-IN-34 can be used for research on non-small cell lung cancer .
Cat. No.: HY-176355S
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
